Immunosuppression and SARS-CoV-2 Infection in Kidney Transplant Recipients by Arnaud Devresse, MD, PhD, Julien De Greef, MD, Jean Cyr Yombi, MD, Leila Belkhir, MD, PhD, Eric Goffin, MD, Nada Kanaan, MD

Get full text

In Reply to ‘Kidney Transplant Recipients With COVID-19 and Monoclonal Antibody Therapy: Additional Considerations’ by Guillaume Fernandes, MD, Arnaud Devresse, MD, PhD, Anais Scohy, PharmD, Julien De Greef, MD, Jean Cyr Yombi, MD, Leila Belkhir, MD, PhD, Tom Darius, MD, PhD, Michel Mourad, MD, PhD, Antoine Buemi, MD, Benoit Kabamba, PharmD, PhD, Eric Goffin, MD, Nada Kanaan, MD

Get full text

Patient Participant Perspectives on Implementation of Long-Acting Cabotegravir and Rilpivirine: Results From the Cabotegravir and Rilpivirine Implementation Study in European Locat... by Cassidy A. Gutner PhD, Marc van der Valk MD, PhD, Joaquin Portilla MD, Eliette Jeanmaire MD, Leïla Belkhir MD, PhD, Thomas Lutz MD, Rebecca DeMoor MSc, Rekha Trehan BSc, Jenny Scherzer MBA, MSc, Miguel Pascual-Bernáldez PharmB, Mounir Ait-Khaled PhD, Beatriz Hernandez PharmD, PhD, Annemiek de Ruiter MBBS, FRCP, Savita Bakhshi Anand PhD, Emma L. Low PhD, Monica Hadi PhD, Nicola Barnes MA, Nick Sevdalis PhD, Perry Mohammed MBBS, Maggie Czarnogorski MD, MPH

Get full text